[Sarcoid-like granulomatosis in cancer patients treated with immune checkpoints inhibitors].

Faviez, G; Bousquet, E; Rabeau, A; Rouquette, I; Collot, S; Goumarre, C; Meyer, N; Prevot, G; Mazieres, J

[Sarcoid-like granulomatosis in cancer patients treated with immune checkpoints inhibitors]. / Granulomatose sarcoïdosique survenant sous inhibiteurs de point de contrôle immunitaire.

Faviez, G; Bousquet, E; Rabeau, A; Rouquette, I; Collot, S; Goumarre, C; Meyer, N; Prevot, G; Mazieres, J.

Afiliação

Faviez G; Service de pneumologie, université Paul-Sabatier, centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France; Centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France.
Bousquet E; Service de pneumologie, université Paul-Sabatier, centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France; Centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France.
Rabeau A; Service de pneumologie, université Paul-Sabatier, centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France; Centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France.
Rouquette I; Service d'anatomopathologie, centre hospitalier universitaire, institut universitaire du cancer, 31059 Toulouse, France.
Collot S; Service de radiologie, centre hospitalier universitaire, hôpital Rangueil, 31059 Toulouse, France.
Goumarre C; Service de médecine nucléaire, CHU de Toulouse, 31059 Toulouse, France.
Meyer N; Service de dermatologie, centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France; Centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France.
Prevot G; Service de pneumologie, université Paul-Sabatier, centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France; Centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France.
Mazieres J; Service de pneumologie, université Paul-Sabatier, centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France; Centre hospitalier universitaire, hôpital Larrey, 31059 Toulouse, France. Electronic address: Mazieres.j@chu-toulouse.fr.

Rev Mal Respir ; 35(9): 963-967, 2018 Nov.

Article em Fr | MEDLINE | ID: mdl-30220489

Assuntos

Anticorpos Monoclonais/efeitos adversos; Antineoplásicos Imunológicos/efeitos adversos; Pontos de Checagem do Ciclo Celular/imunologia; Granuloma/induzido quimicamente; Imunoterapia/efeitos adversos; Neoplasias/terapia; Sarcoidose/induzido quimicamente; Anticorpos Monoclonais/uso terapêutico; Antineoplásicos Imunológicos/uso terapêutico; Granuloma/patologia; Humanos; Imunoterapia/métodos; Masculino; Doenças do Mediastino/induzido quimicamente; Doenças do Mediastino/diagnóstico; Doenças do Mediastino/patologia; Pessoa de Meia-Idade; Neoplasias/patologia; Receptor de Morte Celular Programada 1/imunologia; Sarcoidose/patologia

Palavras-chave

Anti-PD-1/PD-L1; Granulomatose; Granulomatosis; Immune-related adverse events; Immunotherapy; Immunothérapie; Inhibiteurs de checkpoints immunitaires; PD-1/PD-L1 inhibitors; Toxicity; Toxicité

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sarcoidose / Pontos de Checagem do Ciclo Celular / Antineoplásicos Imunológicos / Granuloma / Imunoterapia / Anticorpos Monoclonais / Neoplasias Tipo de estudo: Diagnostic_studies Limite: Humans / Male / Middle aged Idioma: Fr Revista: Rev Mal Respir Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google